businesspress24.com - Healthcare & Medical: Pressemitteilungen - Kategorie - Seite 5
 

Healthcare & Medical

Category / Healthcare & Medical


Everest Medicines Announces 2025 Interim Results: Dual-Engine Strategy Driving Strong Synergies Between Commercialization and R&D

HONG KONG: HONG KONG, Sep 1, 2025 - (ACN Newswire) - On August 29, Everest Medicines (1952.HK) announced its interim results for the six months ended June 30, 2025. The Company’s total revenue for the first ha ...

Everest Medicines New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access

HONG KONG: HONG KONG, Aug 14, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, “Everest”) today announced that the Taiwan Food and Drug Administration (TFDA) has officially accepted the New Drug Appl ...

AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance

Singapore: SINGAPORE, Aug 13, 2025 - (ACN Newswire) - SGX Catalist-listed AsiaMedic Limited (the “Company” and, together with its subsidiaries, the “Group”) announced its unaudited financial results for ...

Everest Medicines Announces Full Approval of NEFECON(R) in Taiwan

HONG KONG: HONG KONG, Aug 8, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) recently announced the Taiwan Food and Drug Administration (TFDA) has approved the supplementary application for NEFECON(R). ...

Cornerstone Robotics Completes Worlds First Clinical Validation of Autonomous Surgery Performed by Robot-Assisted Surgery

HONG KONG: HONG KONG, Aug 6, 2025 - (ACN Newswire) - A major breakthrough in surgical embodied intelligence in Robot-Assisted Surgery (RAS) has been achieved in Hong Kong, China. At a press conference held on 5 ...

NEFECON(R) Receives NMPA Approval for Production Expansion in China, as Everest Medicines Accelerates Accessibility and Capacity Efforts

HONG KONG: HONG KONG, Aug 5, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK) today announced that the supplemental application for the production expansion of NEFECON® has been officially approved by C ...

Everest Medicines Expands Strategic Investment in I-MAB to Advance the Global Value of Its Proprietary Next-Generation Cancer Immunotherapies

HONG KONG: HONG KONG, Aug 2, 2025 - (ACN Newswire) - Everest Medicines (HKEX: 1952.HK) today announced a strategic equity investment in I-Mab (NASDAQ: IMAB), under which Everest will invest US$30.9 million (equi ...

Everest Medicines Announces Share Placement to Raise Approximately HK$1,572.50 Million

Shanghai: SHANGHAI, July 25, 2025 - (ACN Newswire) - Everest Medicines (HKEX 1952.HK, “Everest” or the “Company”), a biopharmaceutical company focused on the discovery, clinical development, manufacturi ...

Olympus Enters Strategic Partnership to Develop Endoluminal Gastrointestinal Robotics

TOKYO: Olympus co-founds Swan EndoSurgical with Revival Healthcare Capital ...

CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets

SINGAPORE,: SINGAPORE, July 21, 2025 - (ACN Newswire) - On July 15 2025, to mark the successful secondary listing of China Medical System Holdings Limited ("CMS" or the "Group") on the Main Bo ...

Cornerstone Robotics Launches First Clinical Evaluation of its Hong Kong-Developed Surgical Robotic System in UK

HONG KONG: HONG KONG, July 9, 2025 - (ACN Newswire) - Cornerstone Robotics (CSR) has announced the first formal clinical investigation of its Hong Kong-developed surgical robotic system at Portsmouth Hospitals U ...

Everest Medicines Unveils Breakthroughs in AI+mRNA Platform, Reinforces Global Leadership in Next-Gen mRNA Innovation

HONG KONG: HONG KONG, July 4, 2025 - (ACN Newswire) - Everest Medicines (HKEX: 1952.HK) recently unveiled major breakthroughs in its proprietary AI-powered mRNA platform during its 2025 R&D Day held in Shang ...

Silo Pharma Enters Letter of Intent for JV with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market

NEW YORK: Technology Co-Developed by the U.S. Department of Veteran Affairs and Emory University ...


Page 5 von 304:  1 « ..  4 5 6  7  8  9  10  11  12  13  .. » 304





 

Who is online

All members: 10 721
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 199


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.